alter the current induced by rTMS [5] making safety and stimulation effects hard to predict. Finally, stroke near the stimulation site could undermine therapeutic efficacy by altering the local or remote network effects of rTMS [6, 7] .
Treatment response was measured using the 24-item Hamilton Psychiatric Rating Scale for Depression (HamD) and The Beck Depression Inventory-II (BDI). Standardized cut-offs for response (a 50% reduction in score on the BDI or Ham-D) and remission (a score ≤12 on the BDI or ≤11 on a 24-item HamD) were used [8] .
Both patients met criteria for response and remission after 30 sessions of rTMS. In Mr. A, BDI improved from 19 to 8 and HAMD improved from 18 to 10. In Ms. B, BDI score improved from 31 to 1 and HamD improved from 23 to 6. In both patients rTMS was safe, well tolerated, with no complications or adverse side effects.
Although limited to two case reports, these data suggest that lowfrequency rTMS over right frontal cortex may be effective in patients with medication-refractory depression and left frontal stroke. Whether the left frontal stroke contributed to depression in these cases is unknown. Our positive clinical results are consistent with data suggesting that low-frequency rTMS to right frontal cortex is effective in primary depression [1, 2] and data suggesting that low frequency stimulation contralateral to the lesion can improve stroke symptoms such as hemiparesis [9] , visual impairments [10] , and neglect [11] . Low frequency stimulation has the added benefit of reducing seizure risk in a patient population at increased risk [5] . 
